Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Fungal Cell Wall: Emerging Antifungals and Drug Resistance

Full text
Author(s):
Lima, Soraia L. [1] ; Colombo, Arnaldo L. [1] ; de Almeida Junior, Joao N. [2]
Total Authors: 3
Affiliation:
[1] Univ Fed Sao Paulo, Lab Especial Micol, Discipline Infectol, Sao Paulo, SP - Brazil
[2] Univ Sao Paulo, Fac Med, Hosp Cin, Cent Lab Div, Sao Paulo, SP - Brazil
Total Affiliations: 2
Document type: Review article
Source: FRONTIERS IN MICROBIOLOGY; v. 10, NOV 21 2019.
Web of Science Citations: 0
Abstract

The cell wall is an essential component in fungal homeostasis. The lack of a covering wall in human cells makes this component an attractive target for antifungal development. The host environment and antifungal stress can lead to cell wall modifications related to drug resistance. Antifungals targeting the cell wall including the new beta-D-glucan synthase inhibitor ibrexafungerp and glycosyl-phosphatidyl Inositol (GPI) anchor pathway inhibitor fosmanogepix are promising weapons against antifungal resistance. The fosmanogepix shows strong in vitro activity against the multidrug-resistant species Candida auris, Fusarium solani, and Lomentospora prolificans. The alternative carbon sources in the infection site change the cell wall beta-D-glucan and chitin composition, leading to echinocandin and amphotericin resistance. Candida populations that survive echinocandin exposure develop tolerance and show high chitin content in the cell wall, while fungal species such as Aspergillus flavus with a higher beta-D-glucan content may show amphotericin resistance. Therefore understanding fungal cell dynamics has become important not only for host-fungal interactions, but also treatment of fungal infections. This review summarizes recent findings regarding antifungal therapy and development of resistance related to the fungal cell wall of the most relevant human pathogenic species. (AU)

FAPESP's process: 17/02203-7 - Multidisciplinary and international network to characterize microbiological aspects and natural history of invasive fungal infections due Candida spp
Grantee:Arnaldo Lopes Colombo
Support Opportunities: Research Projects - Thematic Grants